je.st
news
Merck buys Swiss biotech with promising cancer drug
2014-12-18 19:05:10| Biotech - Topix.net
Drugmaker Merck says it's bought a Swiss biotech company developing cancer drugs as part of its strategy to be a top player in cancer, one of the hottest pharmaceutical research areas. Merck & Co., based in Kenilworth, New Jersey, will pay up to $110 million upfront to OncoEthix.
Tags: drug
cancer
swiss
promising
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||